These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10675984)

  • 1. Structure-activity relationships of polycyclic aromatic amines with calcium channel blocking activity.
    Malan SF; Van der Walt JJ; Van der Schyf CJ
    Arch Pharm (Weinheim); 2000 Jan; 333(1):10-6. PubMed ID: 10675984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure and ion channel activity of 6-benzylamino-3-hydroxyhexa-cyclo[6.5.0.0(3,7).0(4,12).0(5,10).0(9,13]tridecane.
    Malan SF; Dyason K; Wagenaar B; Van Der Walt JJ; Van Der Schyf CJ
    Arch Pharm (Weinheim); 2003 Apr; 336(2):127-33. PubMed ID: 12761766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-nitrosylation and attenuation of excessive calcium flux by pentacycloundecane derivatives.
    Lemmer HJ; Joubert J; van Dyk S; van der Westhuizen FH; Malan SF
    Med Chem; 2012 May; 8(3):361-71. PubMed ID: 22530904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomeric resolution of the calcium channel antagonist 8-benzylamino-8,11-oxapentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]unde cane (NGP 1-01).
    Malan SF; Dockendolf G; Van der Walt JJ; van Rooyen JM; van der Schyf CJ
    Pharmazie; 1998 Dec; 53(12):859-62. PubMed ID: 9879570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.
    Young LM; Geldenhuys WJ; Domingo OC; Malan SF; Van der Schyf CJ
    Arch Pharm (Weinheim); 2016 Apr; 349(4):252-67. PubMed ID: 26892182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor.
    Geldenhuys WJ; Malan SF; Bloomquist JR; Van der Schyf CJ
    Bioorg Med Chem; 2007 Feb; 15(3):1525-32. PubMed ID: 17157509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses, calcium channel agonist-antagonist modulation activities, nitric oxide release, and voltage-clamp studies of 2-nitrooxyethyl 1,4-dihydro- 2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)pyridine-5-carboxylate enantiomers.
    Shan R; Howlett SE; Knaus EE
    J Med Chem; 2002 Feb; 45(4):955-61. PubMed ID: 11831908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of derivatives of NGP 1-01, a putative calcium channel antagonist, on electrically stimulated guinea-pig papillary muscle.
    Liebenberg W; Van der Walt JJ; Van der Schyf CJ
    Pharmazie; 2000 Nov; 55(11):833-6. PubMed ID: 11126000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, evaluation and application of polycyclic fluorescent analogues as N-methyl-D-aspartate receptor and voltage gated calcium channel ligands.
    Joubert J; van Dyk S; Green IR; Malan SF
    Eur J Med Chem; 2011 Oct; 46(10):5010-20. PubMed ID: 21868136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies in the field of calcium antagonists. Xanthone 1,4-dihydropyridines bearing a 2,3-lactone ring.
    Rampa A; Budriesi R; Bisi A; Fabbri G; Barili PL; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Sep; 45(9):957-62. PubMed ID: 7488312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel calcium antagonists. Synthesis and structure-activity relationship studies of benzothiazoline derivatives.
    Yamamoto K; Fujita M; Tabashi K; Kawashima Y; Kato E; Oya M; Iso T; Iwao J
    J Med Chem; 1988 May; 31(5):919-30. PubMed ID: 3361580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fendiline inhibits L-type calcium channels in guinea-pig ventricular myocytes: a whole-cell patch-clamp study.
    Tripathi O; Schreibmayer W; Tritthart HA
    Br J Pharmacol; 1993 Apr; 108(4):865-9. PubMed ID: 8485628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
    Atwal KS; Bergey JL; Hedberg A; Moreland S
    J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes.
    Bryant SM; Hart G
    Br J Pharmacol; 1996 Jul; 118(6):1455-60. PubMed ID: 8832072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.
    Campiani G; Garofalo A; Fiorini I; Botta M; Nacci V; Tafi A; Chiarini A; Budriesi R; Bruni G; Romeo MR
    J Med Chem; 1995 Oct; 38(22):4393-410. PubMed ID: 7473567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycyclic aromatic compounds as anticancer agents: synthesis and biological evaluation of dibenzofluorene derivatives.
    Becker FF; Mukhopadhyay C; Hackfeld L; Banik I; Banik BK
    Bioorg Med Chem; 2000 Dec; 8(12):2693-9. PubMed ID: 11131160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease.
    Geldenhuys WJ; Malan SF; Murugesan T; Van der Schyf CJ; Bloomquist JR
    Bioorg Med Chem; 2004 Apr; 12(7):1799-806. PubMed ID: 15028270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.